Benchmark Co. Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1.25
Analysts Offer Insights on Healthcare Companies: Milestone Scientific (MLSS), Neurocrine (NBIX) and Argenx Se (ARGX)
Express News | Milestone Scientific FY 2024 GAAP EPS $(0.06) Misses $(0.05) Estimate, Sales $8.630M Miss $9.261M Estimate
Express News | Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
Press Release: Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
Milestone Scientific | 10-K: FY2024 Annual Report
THE MILESTONE GROUP ACQUIRES 252-UNIT SOLAIRE APARTMENTS IN BRIGHTON, CO
Milestone Scientific Expands CompuFlo Epidural System Footprint With InfiniSurg, LLC in New Jersey
Milestone Scientific Delays Yearly Report Filing
$MLSS Earnings Preview: Recent $MLSS Insider Trading, Hedge Fund Activity, and More
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Milestone Scientific Announces Commercial Rollout of CompuFlo Epidural System at Advanced Spine and Pain Management Following Successful Pilot With Dr. Varinder Dhillon
NYSE American New 52-Week Highs And Lows
Milestone Scientific Director Resigns Amid Personal Reasons
Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
Milestone Structural Solutions Highlights Superior Craftsmanship in Structural and Miscellaneous Steel Detailing for Chapin High School's New 5-Story Football Stadium Press Box
Milestone Scientific Secures Federal Supply Schedule Approval On Contract For CompuFlo Epidural System
Express News | Milestone Scientific Secures Federal Supply Schedule (Fss) Approval on Contract for Compuflo® Epidural System
Express News | Benchmark Reiterates Speculative Buy on Milestone Scientific, Maintains $1.25 Price Target
Milestone Scientific Analyst Ratings